MEMBER'S LOGINX
| Invalid Username / Password | ||||||||
| Invalid Captcha | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
Our Big Prediction
This Could be One of the Exciting Opportunities for Investors
- Home
- Stock Quote
- Sector Info (List of diagnostics Stocks)
- List of Diagnostics Stocks
List of Diagnostics
Stocks 
Here are the latest stock price details of India's top Diagnostics stocks. For more detailed updates, check the latest Diagnostics sector results.
| SCRIP | BSE PRICE (Rs) | NSE PRICE (Rs) | CHART | MORE INFO |
|---|---|---|---|---|
| DR. LAL PATHLABS | 3,040.90 2.45% | 3,041.45 2.48% |
|
More Info
|
| GLOBAL HEALTH | 1,086.40 0.56% | 1,091.90 1.02% |
|
More Info
|
| KRSNAA DIAGNOSTICS | 933.15 0.70% | 934.50 0.91% |
|
More Info
|
| METROPOLIS HEALTHCARE | 2,016.95 -0.35% | 2,020.70 -0.02% |
|
More Info
|
| NIFTY 50 | Not Listed | 23,518.50 0.28% |
|
More Info
|
| RAINBOW CHILDRENS MEDICARE | 1,577.00 -1.20% | 1,578.50 -1.10% |
|
More Info
|
| S&P BSE SENSEX | 77,578.38 0.31% | Not Listed |
|
More Info
|
| THYROCARE TECHNOLOGIES | 964.70 -1.86% | 963.15 -2.20% |
|
More Info
|
| VIJAYA DIAGNOSTIC | 1,068.30 5.87% | 1,068.75 5.92% |
|
More Info
|
BSE prices: November 19, 2024 (Close) NSE prices: November 19, 2024 (Close)
Diagnostics Stocks Update
Within the Diagnostics sector, the top gainers were VIJAYA DIAGNOSTIC (up 5.9%) and DR. LAL PATHLABS (up 2.5%). On the other hand, THYROCARE TECHNOLOGIES (down 1.9%) and RAINBOW CHILDRENS MEDICARE (down 1.2%) were among the top losers.
Meanwhile, the benchmark S&P BSE SENSEX was at 77,578.4 (up 0.3%).
FAQs
Which are the top diagnostics companies in India?
Based on marketcap, these are the top diagnostics companies in India:
- #1 GLOBAL HEALTH
- #2 DR. LAL PATHLABS
- #3 RAINBOW CHILDRENS MEDICARE
- #4 VIJAYA DIAGNOSTIC
- #5 METROPOLIS HEALTHCARE
You can see the full list of diagnostics stocks here.
And for a fundamental analysis of the above companies, check out Equitymaster’s Indian stock screener which has a separate screen for best diagnostics companies in India.
Which are the top gainers and top losers within the diagnostics sector today?
Within the Diagnostics sector, the top gainers were VIJAYA DIAGNOSTIC (up 5.9%) and DR. LAL PATHLABS (up 2.5%). On the other hand, THYROCARE TECHNOLOGIES (down 1.9%) and RAINBOW CHILDRENS MEDICARE (down 1.2%) were among the top losers.
For more, please visit the BSE healthcare index live chart and also check out our pharma sector report.
How should you value diagnostics companies?
Investing in stocks requires careful analysis of financial data to find out a company's true worth. However, an easier way to find out about a company's performance is to look at its financial ratios.
Two commonly used financial ratios used in the valuation of stocks are -
Price to Earnings Ratio (P/E) - It compares the company's stock price with its earnings per share. The higher the P/E ratio, the more expensive the stock.
Price to Book Value Ratio (P/BV) - It compares a firm's market capitalization to its book value. A high P/BV indicates markets believe the company's assets to be undervalued and vice versa.
To know more about the healthcare sector's past and ongoing performance, have a look at the performance of the NIFTY healthcare index and BSE healthcare index.
Which are some important indices one should track?
Well, it depends on what your goals are.
Having said that, the two key indices to track are the BSE Sensex which contains the list of BSE 30 stocks and the NSE Nifty which contains the list of NSE 50 stocks.
However, these two indices are considered to be too narrow by some, since they only track 30 and 50 stocks, respectively.
For broader tracking, you could use the BSE 200, BSE 500 or even the NSE 500 index.
Some popular market cap based indices include BSE Smallcap index and BSE Midcap index, among others.
Today's Market
![Sensex Today Ends 239 Points Higher | Nifty Above 23,500 | HDFC Bank & Tech Mahindra Top Gainers]()
Sensex Today Ends 239 Points Higher | Nifty Above 23,500 | HDFC Bank & Tech Mahindra Top Gainers(Closing)
On Tuesday, Indian share markets traded on a positive note throughout the session and ended marginally higher.
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
- Multibagger Penny Stocks
- Basics of Value Investing
- Benjamin Graham
- How to Invest in Gold
- How to Invest in Silver
- Best Stocks to Buy Today
- Best Small-cap Stocks to Buy
- Best Bluechip Stocks to Buy
- Guide to Penny Stocks
- How to Invest in the Share Market
- Warren Buffett - The Value Investor
- Pick the Best Multibagger Stocks
TRENDING TOPICS
Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407
Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com
LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.